HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fidexaban

structure in first source
Also Known As:
CI-1031; N-(2-(5-(amino(imino)methyl)-2-hydroxyphenoxy)-3,5-difluoro-6-(3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy)pyridin-4-yl)-N-methylglycine; ZK 807834; ZK-807834
Networked: 10 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Morser, J: 4 articles (12/2004 - 08/2001)
2. Light, D R: 4 articles (09/2003 - 05/2000)
3. Abendschein, D R: 3 articles (09/2003 - 05/2000)
4. Baum, P K: 3 articles (09/2003 - 05/2000)
5. Sullivan, M E: 3 articles (12/2001 - 05/2000)
6. Leadley, Robert: 2 articles (03/2007 - 02/2002)
7. Eisenberg, P R: 2 articles (02/2001 - 05/2000)
8. Chesebro, James H: 1 article (03/2007)
9. Crook, Julia: 1 article (03/2007)
10. Farkouh, Michael E: 1 article (03/2007)

Related Diseases

1. Venous Thrombosis (Deep-Vein Thrombosis)
2. Thrombosis (Thrombus)
3. Hemorrhage
4. Vascular System Injuries
5. Vascular Diseases (Vascular Disease)

Related Drugs and Biologics

1. Factor Xa (Coagulation Factor Xa)
2. (2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acid
3. tick anticoagulant peptide
4. Factor Xa Inhibitors
5. Copper
6. Enoxaparin (Lovenox)
7. Thromboplastin (Tissue Factor)
8. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
9. Heparin (Liquaemin)
10. Fibrinolytic Agents (Antithrombotic Agents)

Related Therapies and Procedures

1. Catheters